Trial Profile
Effects of SUlodexide on damaged endothelial Glycocalyx in pAtients with diabetes Mellitus type two: Reversing damage
Status:
Active, no longer recruiting
Phase of Trial:
Phase II
Latest Information Update: 17 Sep 2011
Price :
$35
*
At a glance
- Drugs Sulodexide (Primary)
- Indications Diabetic nephropathies; Embolism and thrombosis; Proteinuria; Type 2 diabetes mellitus
- Focus Pharmacodynamics
- Acronyms SUGAR
- 19 Jan 2010 Status changed from recruiting to active, no longer recruiting as reported by Netherlands Trial Register.
- 04 Jan 2007 New trial record.